Mingjun Bi
Impact in
-
- Cancer-related molecular mechanisms research
-
- Hippo pathway signaling and YAP/TAZ
Papers in
-
- Cancer-related gene regulation 3
- RNA Research and Splicing 3
- Genomics and Chromatin Dynamics 2
- RNA modifications and cancer 2
- CRISPR and Genetic Engineering 2
-
- Cancer-related molecular mechanisms research 4
- Co-authors
- Bin Huang (1 shared paper)Hongmei Yu (1 shared paper)Zhijie Liu (3 shared papers)Karen Hernandez (1 shared paper)Chi Zhu (1 shared paper)Junqiang Chen (1 shared paper)Hu Wang (1 shared paper)Jia Tong (2 shared papers)
- Journals
- Transgenic Research (2 papers)PLoS ONE (1 paper)RNA Biology (1 paper)Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (1 paper)Cell Reports (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Mingjun Bi
13 papers receiving 280 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 70
- Cell Biology 54
- Molecular Biology 199
- Genetics 55
- Immunology 16
Countries citing papers authored by Mingjun Bi
This map shows the geographic impact of Mingjun Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjun Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjun Bi more than expected).
Fields of papers citing papers by Mingjun Bi
This network shows the impact of papers produced by Mingjun Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjun Bi. The network helps show where Mingjun Bi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingjun Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 85 | |
| 2 | 2010 | 47 | |
| 3 | 2017 | 45 | |
| 4 | 2014 | 35 | |
| 5 | 2020 | 18 | |
| 6 | 2023 | 15 | |
| 7 | 2020 | 13 | |
| 8 | 2020 | 9 | |
| 9 | 2012 | 9 | |
| 10 | 2016 | 6 | |
| 11 | 2020 | 2 | |
| 12 | 2015 | 1 | |
| 13 | 2018 | 1 |
About Mingjun Bi
Mingjun Bi is a scholar working on Molecular Biology, Cancer Research, Genetics, Public Health, Environmental and Occupational Health and Neurology, having authored 13 papers that have together received 286 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Animal Genetics and Reproduction (3 papers), Cancer-related gene regulation (3 papers), RNA Research and Splicing (3 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers), Genomics and Chromatin Dynamics (2 papers), RNA modifications and cancer (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Cancer Research (70 citations), Cell Biology (54 citations), Molecular Biology (199 citations), Genetics (55 citations) and Immunology (16 citations). Mingjun Bi has collaborated with scholars based in China and United States. Frequent co-authors include Bin Huang, Hongmei Yu, Zhijie Liu, Karen Hernandez, Chi Zhu, Junqiang Chen, Hu Wang, Jia Tong, Lizhen Chen and Hengxi Wei. Their work appears in journals such as Transgenic Research, PLoS ONE, RNA Biology, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.